Difficulty: Medium
Average Score: 64%
Practice
Problems associated with proton pump inhibitors include:
Correct answer
A
Rationale
The correct answer is A) Masking symptoms of gastric cancer.
Proton pump inhibitors (PPIs) are commonly used to treat gastrointestinal disorders by reducing the production of stomach acid. However, one potential problem associated with PPI use is that they can mask the symptoms of gastric cancer. Gastric cancer can present with symptoms such as stomach pain, indigestion, and heartburn, which are also common symptoms of conditions that PPIs are used to treat. By suppressing acid production, PPIs can alleviate these symptoms, leading to a delay in the diagnosis of gastric cancer.
Option B) Diarrhoea, nausea, and vomiting are not typically associated with PPI use. These side effects are more commonly seen with other medications or gastrointestinal conditions.
Option C) Increased risk of gastrointestinal infection is not a well-documented problem with PPI use. While long-term PPI use may have some associations with certain infections, it is not a primary concern associated with these medications.
Option D) Headache is a relatively uncommon side effect of PPI use and is not a significant problem compared to other potential complications like masking symptoms of gastric cancer.
Educationally, understanding the potential pitfalls of PPI use is crucial for healthcare providers to ensure appropriate diagnosis and management of gastrointestinal conditions. Recognizing the risk of masking symptoms of serious conditions like gastric cancer highlights the importance of judicious use of PPIs and thorough evaluation of patients with persistent or concerning symptoms.
Proton pump inhibitors (PPIs) are commonly used to treat gastrointestinal disorders by reducing the production of stomach acid. However, one potential problem associated with PPI use is that they can mask the symptoms of gastric cancer. Gastric cancer can present with symptoms such as stomach pain, indigestion, and heartburn, which are also common symptoms of conditions that PPIs are used to treat. By suppressing acid production, PPIs can alleviate these symptoms, leading to a delay in the diagnosis of gastric cancer.
Option B) Diarrhoea, nausea, and vomiting are not typically associated with PPI use. These side effects are more commonly seen with other medications or gastrointestinal conditions.
Option C) Increased risk of gastrointestinal infection is not a well-documented problem with PPI use. While long-term PPI use may have some associations with certain infections, it is not a primary concern associated with these medications.
Option D) Headache is a relatively uncommon side effect of PPI use and is not a significant problem compared to other potential complications like masking symptoms of gastric cancer.
Educationally, understanding the potential pitfalls of PPI use is crucial for healthcare providers to ensure appropriate diagnosis and management of gastrointestinal conditions. Recognizing the risk of masking symptoms of serious conditions like gastric cancer highlights the importance of judicious use of PPIs and thorough evaluation of patients with persistent or concerning symptoms.